Interestingly, overactivation of cytosine-cytosine-adenosine-adenosine-thymidine (CCAAT)/-enhancer-binding protein homologous protein (CHOP), another PERK downstream target, has been recently found to be strictly associated with the occurrence of all hallmarks of AD. Here, EIF2AK3 is linked to Alzheimer disease.